[Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy].

Author: BonnetH, DuffauP, Longy-BoursierM, RaffrayL, RivièreP

Paper Details 
Original Abstract of the Article :
Intravesical therapy with bacillus Calmette-Guérin (BCG) has proved to be effective in the treatment of superficial bladder tumors. Side-effects include local infections and rarely disseminated BCG infection with multiple end organ complications such as granulomatous hepatitis, pneumonitis, aortitis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.revmed.2014.10.361

データ提供:米国国立医学図書館(NLM)

A Widespread Infection: Granulomatous Hepatitis Unveils BCG Therapy Complications

Bacillus Calmette-Guérin (BCG) therapy is a widely used treatment for superficial bladder tumors, but it can also lead to complications. This case report describes a patient who developed granulomatous hepatitis, a rare but serious complication of BCG therapy. The researchers investigated the cause of this complication, highlighting the potential for BCG to cause widespread infection in the body.

BCG Therapy: A Double-Edged Sword

The case report reveals that BCG therapy, while effective for treating bladder tumors, can also lead to disseminated BCG infection, affecting multiple organs. The researchers discovered that the patient's granulomatous hepatitis was linked to a widespread BCG infection, underscoring the importance of vigilant monitoring for potential complications during BCG treatment. It's like a desert storm, initially bringing beneficial rainfall but later causing widespread damage if not carefully managed.

Navigating the Risks of BCG Therapy

This case report underscores the need for vigilance in managing patients undergoing BCG therapy. Clinicians must be aware of the potential for disseminated BCG infection and monitor patients closely for any signs of complications. It's a reminder that even the most effective treatments can carry risks, requiring careful consideration and a proactive approach to managing potential complications. Just as a camel caravan must navigate a desert with caution to avoid hazards, we must approach BCG therapy with careful observation and preparedness to address any potential risks.

Dr.Camel's Conclusion

This case report serves as a valuable reminder of the potential complications associated with BCG therapy. By understanding the risks and recognizing the importance of vigilant monitoring, clinicians can ensure the safety and effectiveness of this treatment for bladder cancer patients.

Date :
  1. Date Completed 2016-06-29
  2. Date Revised 2016-10-18
Further Info :

Pubmed ID

25467298

DOI: Digital Object Identifier

10.1016/j.revmed.2014.10.361

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.